Keynumbers for: PharmaLundensis

 6/30/201012/31/20106/30/201112/31/20116/30/201212/31/2012
Number of months that the report spans612612612
Total revenue (MSEK)0.0111.56000.000.09
Earnings before interest and taxes (EBIT) (MSEK)-1.84-3.27-1.18-2.85-1.84-5.03
Pre tax profit (PTP) (MSEK)-1.84-3.27-1.18-2.86-1.84-5.03
Net Revenue (MSEK)-1.87-3.30-1.19-2.86-1.84-5.03
Earnings per share (SEK)-0.14-0.24-0.09-0.20-0.12-0.31
Dividend per share (SEK)-0----
Owner's equity (MSEK)5.233.792.533.154.137.65
Fixed assets (MSEK)1.021.222.112.302.502.70
Intangible assets (MSEK)---2.302.502.70
Liquid assets (MSEK)0.693.051.291.832.385.88
Total shareholder equity and liabilities (MSEK)--3.394.134.888.58
Long time debts including distributions (MSEK)0.130.030---
Short term debt (MSEK)1.180.440.860.980.750.93
The share's ratio value (SEK)0.050.050.050.050.050.05
Cash flow for the period (MSEK)---1.48-1.46-0.573.95
Number of shares (in millions)--13 667 50014 182 46714 782 46716 082 467
Average number of employees------

  • Danderydsgatan 10
  • 114 86 Stockholm
  • Telefon: 08 - 545 038 00
  • Fax: 08 - 611 35 62
  • info(snabel-a)aktietorget(punkt)se